The Southern African Journal of Gynaecological Oncology (SAJGO) is the official journal of the South African Society of Gynaecologic Oncology (SASGO) and the South African Society of Clinical and Radiation Oncology (SASCRO).

The Journal aims to be the prime journal on women’s cancer for local healthcare workers and gynaecologists, focusing on all aspects of cancer prevention, detection, diagnosis and treatment. The SAJGO is also a specialist journal catering for sub-specialist gynaecologic oncologists, for other specialists with a specific interest in breast and gynaecologic cancer, including medical oncologists, radiation oncologists, surgeons, radiologists, pathologists, geneticists, specialised nurses and research scientists.

The Journal supports the vision of SASGO, namely to promote excellence in gynaecologic cancer care and will also aim to promote excellence in breast cancer care. The Journal also supports the mission of the society and will assist SASGO with all aspects of communication, training, advocacy and by supporting and stimulating local research.

Achieving a sustainable Festive Season

Keeping the holidays eco-friendly may seem like a daunting and perhaps, at times, even a somewhat impossible task. However, there are entirely manageable strategies to ensure that you can celebrate the Festive Season fully while also achieving sustainability. The Festive Season is often a time where waste increases. Many products that are not eco-friendly and/or biodegradable are used in large supply. The increased use of plastics, electricity, water and cleaning products lead to a real threat on sustainability – putting your health, your loved ones’ health, and the environment at risk.

Notification of permanent price reduction for Gemzar 200 mg and Gemzar 1 g

Eli Lilly (SA) (PTY) Limited is pleased to announce a 36.6% permanent price reduction for Gemzar 200 mg and for Gemzar 1 g effective 29 November 2019. Gemzar has been in South Africa for 24 years for the management of NSCLC, breast cancer, pancreatic cancer, recurrent epithelial ovarian cancer, and transitional cell bladder cancer.

SmartCRUTCH is the safest, most comfortable, technically advanced crutch ever designed and manufactured – Now available in South Africa

SmartCrutch’s CEO, Colin Albertyn, is the designer, founder and manufacturer of this new innovative SmartCrutch. SmartCrutch has impressed many internationally with its new unique crutch, the SmartCrutch is engineered with robust and durable materials and is available online and through appointed distributors in 15 countries.

Liquid replacement in a lolly

We’ve all been there – when we have a sick child with a fever, diarrhoea or vomiting and as parents, one of our main concerns is how best to replace all those lost fluids. What makes it worse is that often the last thing a sick child feels like is drinking anything. Fortunately, Créche Guard, South Africa’s number 1 children’s multivitamin and mineral supplement, has launched a new product to assist with fluid and nutrient replenishment in children, in a lolly format.

What makes the Norflex range different

With the myriad of muscle relaxants and gels on the market, it can be difficult to know which treatment is right for your patient. Muscle strains and spasms are common. When a patient presents with everyday muscle strains or spasms caused by injury, sport or work-related accidents, the Norflex® range should be your first choice. Not only is Norflex® South Africa’s most prescribed muscle relaxant brand, it also has proven efficacy, with generally tolerable side effects and can assist in the treatment of painful musculoskeletal conditions with associated muscle spasm.

Wildcard SSL